Medicare Enrolled

Dr. Jose Menajovsky, MD

Infectious Disease · West Palm Beach, FL
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
2580 METROCENTRE BLVD STE 3, West Palm Beach, FL 33407
5618326770
Registered in NPPES since 2008
NPI: 1720231459 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Menajovsky from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Menajovsky? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Menajovsky

Dr. Jose Menajovsky is an infectious disease specialist in West Palm Beach, FL, with 17 years of NPI registration. Based on federal Medicare data, Dr. Menajovsky performed 2,618 Medicare services in 2023. These records do not provide a deduplicated patient total.

Between the years covered by Open Payments, Dr. Menajovsky received a total of $17,905 from 28 pharmaceutical and/or device companies across 1159 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Menajovsky is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 17 years of NPI registration ▲ Top 22% volume in FL $17,905 industry payments

Medicare Practice Summary — 2023

Medicare Utilization ↗
2,618
Medicare services
Top 22% in FL for infectious disease
Not available
Unique patients (not deduplicated)
$102
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Hospital follow-up visit, high complexity
Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter.
1,203 $99 $125
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
410 $104 $160
Hospital follow-up visit, moderate complexity
Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service.
401 $66 $95
Initial hospital admission, moderate complexity
Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter.
248 $109 $170
Initial hospital admission, high complexity
Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter.
163 $145 $250
Removal of central venous port or pump
A procedure to remove a central venous access device, such as a port or pump, from the body.
46 $189 $350
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
41 $139 $300
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
33 $75 $120
Critical care, first 30-74 min
Emergency medical care for a critically ill or injured patient lasting between 30 and 74 minutes. This service involves direct patient care and medical decision making to stabilize the patient.
30 $181 $350
Home health plan of care certification
Certification by a physician or allowed practitioner for Medicare-covered home health services under a home health plan of care. This includes contacting the home health agency and reviewing reports of patient status required by physicians.
27 $43 $80
New patient office visit, complex (60-74 min) 16 $184 $350
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.

Industry Payment Transparency

Open Payments through 2024 ↗
$17,905
Total received (2018-2024)
Avg $2,558/year across 7 years
Top 10% in FL for infectious disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
28
Companies
1,159
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →

Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$3,498
2023
$2,952
2022
$2,977
2021
$2,764
2020
$2,695
2019
$1,496
2018
$1,522

Payments by company (2024)

ViiV Healthcare Company
$1,112
Gilead Sciences, Inc.
$995
Merck Sharp & Dohme LLC
$251
Insmed, Inc.
$245
ABBVIE INC.
$237
Shionogi Inc
$178
Paratek Pharmaceuticals, Inc.
$162
Melinta Therapeutics, LLC
$160
Theratechnologies Inc.
$158
Top 3 companies account for 67.4% of 2024 payments
All-time payments by company (2018-2024) ›
Gilead Sciences, Inc.
$5,057
ViiV Healthcare Company
$3,725
Janssen Biotech, Inc.
$1,797
Insmed, Inc.
$1,546
Merck Sharp & Dohme LLC
$800
Merck Sharp & Dohme Corporation
$688
Melinta Therapeutics, LLC
$643
Theratechnologies Inc.
$609
Paratek Pharmaceuticals, Inc.
$489
ABBVIE INC.
$454
Janssen Products, LP
$298
AbbVie Inc.
$277
Shionogi Inc
$248
AbbVie, Inc.
$231
VYERA PHARMACEUTICALS, LLC
$184
Allergan Inc.
$137
Allergan, Inc.
$134
La Jolla Pharmaceutical Company
$127
TETRAPHASE PHARMACEUTICALS, INC.
$110
Melinta Therapeutics, Inc.
$86
EMD Serono, Inc.
$60
Mylan Specialty L.P.
$50
Janssen Scientific Affairs, LLC
$40
MAYNE PHARMA INC.
$36
Nabriva Therapeutics, plc
$32
Takeda Pharmaceuticals U.S.A., Inc.
$18
Mylan Pharmaceuticals Inc.
$18
Janssen Pharmaceuticals, Inc
$13
Top 3 companies account for 59.1% of all-time payments
Associated products mentioned in payments ›
APRETUDE · AVYCAZ · Arikayce · Baxdela · CABENUVA · DALVANCE · DIFICID · DOVATO · Daraprim · EGRIFTA · Fetroja · GATTEX · ISENTRESS · JULUCA · Kimyrsa · MAVYRET · Mavyret · NOXAFIL · NUZYRA · Orbactiv · PIFELTRO · PREZCOBIX · RUKOBIA · Rezzayo · SEROSTIM · SYMTUZA · Serostim · Symfi · Symtuza · TEFLARO · TIVICAY · TRIUMEQ · TROGARZO · Vabomere · Veklury · XARELTO · XERAVA · Xenleta · Xerava · Yupelri · ZERBAXA
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Looking for an infectious disease specialist in West Palm Beach?
Compare infectious diseases in the West Palm Beach area by procedure volume, costs, and industry payment transparency.
Browse infectious diseases nearby

Geographic Context

Infectious diseases in nearby ZIP areas
41
County median income
$81,115
Nearest hospital to ZIP centroid (approximate)
ST MARY'S MEDICAL CENTER
0.0 mi

Data Sources

Provider Registry NPPES NPPES snapshot; verify current record
Medicare Enrollment PECOS PECOS snapshot
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not included N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Menajovsky is a clinical cardiology specialist, with above-average Medicare volume (top 22% in FL), with 17 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Menajovsky experienced with hospital follow-up visit, high complexity?
Based on Medicare claims data, Dr. Menajovsky performed 1,203 hospital follow-up visit, high complexity services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Menajovsky receive payments from pharmaceutical companies?
Yes. Dr. Menajovsky received a total of $17,905 from 28 companies across 1,159 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Menajovsky's costs compare to other infectious diseases in West Palm Beach?
Dr. Menajovsky's average Medicare payment per service is $102. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Menajovsky) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
About this page

This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Industry payment disclosure alone establishes neither wrongdoing nor legality. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →